Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Spire Healthcare ( (GB:SPI) ) has provided an announcement.
Spire Healthcare has confirmed it has received a non-binding proposal from Toscafund, its second-largest shareholder, for a possible 250p-per-share cash offer for the entire company, with an option for shareholders to elect an unlisted rollover equity alternative. The approach comes amid an ongoing strategic review and follows earlier proposals from Toscafund, with the latest offer subject to due diligence and agreement of definitive terms.
The board, which highlights strong recent gains in cash flow and returns on capital, says it is minded to unanimously recommend the proposal if it becomes a firm offer on those financial terms, while cautioning there is no certainty a bid will materialise. Toscafund faces a regulatory deadline of 11 June 2026 to announce a firm intention to bid or walk away, and in the meantime Spire continues to pursue its standalone strategy focused on private pay growth, integrated care and further cost efficiencies.
The most recent analyst rating on (GB:SPI) stock is a Buy with a £2.75 price target. To see the full list of analyst forecasts on Spire Healthcare stock, see the GB:SPI Stock Forecast page.
Spark’s Take on SPI Stock
According to Spark, TipRanks’ AI Analyst, SPI is a Neutral.
The score is primarily supported by solid operating performance and consistent cash generation, but it is weighed down by high leverage and weak bottom-line profitability. Technical indicators are notably weak with the price below key moving averages and negative MACD, and valuation also detracts due to a high P/E with only a modest dividend yield.
To see Spark’s full report on SPI stock, click here.
More about Spire Healthcare
Spire Healthcare is a leading independent healthcare group in the UK, operating 38 hospitals and more than 60 clinics across England, Wales and Scotland. It partners with over 8,800 consultants to deliver private, NHS and employer-funded services, and is the largest private provider of knee and hip operations and NHS talking therapies by volume in the country.
The group runs a network of private GPs and workplace health services for over 1,400 employers, alongside mental health, musculoskeletal and dermatology offerings. Nearly all of its roughly 100 clinical sites are rated Good or Outstanding by regulators, and the company is listed on the London Stock Exchange as a member of the FTSE 250 index.
Average Trading Volume: 1,466,629
Technical Sentiment Signal: Sell
Current Market Cap: £594.7M
Learn more about SPI stock on TipRanks’ Stock Analysis page.